Ming-Shun Wu

Title: The Innovative Contributions of Ming-Shun Wu

Introduction

Ming-Shun Wu is a notable inventor based in Taipei, Taiwan. He has made significant strides in the field of biotechnology, particularly in the treatment of viral infections. His work focuses on utilizing natural resources to combat health issues, showcasing the potential of innovative solutions in medicine.

Latest Patents

Ming-Shun Wu holds a patent for the "Use of cyanobacterial biomass in treating hepatitis B virus infection." This patent discloses the use of cyanobacterial biomass for treating hepatitis B virus (HBV) infection, especially chronic HBV infection. The findings indicate that after at least one month of administration, the cyanobacterial biomass significantly reduces the level of the surface antigen of hepatitis B virus (HBsAg) detectable in the subject receiving the treatment. Additionally, it helps mitigate insomnia associated with chronic HBV infection.

Career Highlights

Ming-Shun Wu is associated with Far East Bio-Tec Co., Ltd., where he contributes his expertise in biotechnology and innovation. His work has been instrumental in advancing treatments for viral infections, demonstrating his commitment to improving public health through scientific research.

Collaborations

Ming-Shun Wu collaborates with talented individuals such as Chuang-Chun Chiuh and Yi-Hsiang Chen. Their combined efforts in research and development have led to significant advancements in their field.

Conclusion

Ming-Shun Wu's innovative contributions to the treatment of hepatitis B virus infection highlight the importance of research and development in biotechnology. His work exemplifies how natural resources can be harnessed to create effective medical treatments.